[ad_1] The Bureau of Labor Statistics’ (BLS’) Prescription Drug Consumer Price Index (CPI‐Rx) looks at price changes for drugs dispensed at outpatient retail pharmacies. However, […]
[ad_1] Medical debt in the U.S. is a major problem. While over 90% of individuals have health insurance, many people […]
[ad_1] Samsung Bioepis has a Biosimilar Market Report for Q2 2024. Some key highlights: As of April 2024, the FDA […]
[ad_1] By MATTHEW HOLT I am dipping into two rumbling controversies that probably only data nerds and chronic care management nerds care about, but as […]
[ad_1] By KIM BELLARD Among the many things that infuriate me about the U.S. healthcare system, health systems sending their patients to collections – or […]
[ad_1] For patients with serious illnesses, timeline access to efficacious medications is paramount. The European Medicines Agency (EMA) was created in part to help expedite […]
[ad_1] By KELLY CARROLL There is a dire need to raise awareness about heart disease in women. It is the number one killer of American […]
[ad_1] By MIKE MAGEE How comfortable is the FDA and Medical Ethics community with a new super-charged medical Facial Recognition Technology (mFRT) that claims it […]
[ad_1] A paper by Kogut (2024) has a nice overview of the organizations that develop pharmacy plan quality metrics. Pharmacy plan quality is vital since […]
[ad_1] By KMI BELLARD I’ve been thinking a lot about infrastructure. In particular, what to do when it fails. There was, of course, the tragic […]